REQUEST A DEMO
Total
USD $0.00
Search more companies

E.S.E. Centro Dermatologico Federico Lleras Acosta (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: E.S.E. Centro Dermatologico Federico Lleras Acosta Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

E.S.E. Centro Dermatologico Federico Lleras Acosta is a dermatological research and teaching center. It is recognized as a Research Center by Colciencias and focuses on tropical dermatology and general dermatology.

Headquarters
Av. 1 13 A - 61
Bogota D.C.; Bogota D.C; Postal Code: 111511

Contact Details: Purchase the E.S.E. Centro Dermatologico Federico Lleras Acosta report to view the information.

Website: http://www.dermatologia.gov.co

Basic Information
Outstanding Shares:
Purchase the E.S.E. Centro Dermatologico Federico Lleras Acosta report to view the information.
Incorporation Date:
December 18, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Head of Internal Control
Company Performance
Financial values in the chart are available after E.S.E. Centro Dermatologico Federico Lleras Acosta report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-3.23%
Total operating revenue
5.56%
Operating profit (EBIT)
310.43%
EBITDA
80.55%
Net Profit (Loss) for the Period
688.37%
Total assets
3.17%
Total equity
5.52%
Operating Profit Margin (ROS)
6%
Net Profit Margin
6.54%
Return on Equity (ROE)
2.37%
Quick Ratio
0.84%
Cash Ratio
0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?